INO SCHEDULE 13G/A: SEC filing
An amendment to a Schedule 13G was
Filed with the SEC on · accession 0000919574-26-004959
INO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 12, 2026. An amendment to a Schedule 13G was filed regarding Inovio Pharmaceuticals, indicating a change in a passive institutional holder's ownership position. The stock moved +0.5% by the first close after the filing.
Summary of the filing
An amendment to a Schedule 13G was filed regarding Inovio Pharmaceuticals, indicating a change in a passive institutional holder's ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
Key details
How INO stock reacted
Close before
$0.77
Aug 11, 2026
First close after
+0.55%
$0.77
5 trading days
+56.70%
$1.20
Since filing
+58.66%
$1.22
✦ Ask GOAX AI about this filing — what it means for INO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for INO?
Click hereFrequently asked questions
What did INO file with the SEC on Aug 12, 2026?
INO filed a SCHEDULE 13G/A (SEC filing). An amendment to a Schedule 13G was filed regarding Inovio Pharmaceuticals, indicating a change in a passive institutional holder's ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did INO stock react to this filing?
INO closed at $0.77 before the filing and $0.77 on Aug 12, 2026 (+0.55%). Five trading days later: $1.20 (+56.70%).
Other INO SEC filings
- 424B5 · Secondary offeringNov 6, 2026
- SCHEDULE 13G/A · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Fda approvalNov 2, 2026
- 8-K · SEC filingOct 6, 2026
- 10-Q · SEC filingAug 12, 2026
- 8-K · SEC filingAug 12, 2026
- 8-K · Secondary offeringJul 31, 2026
- 424B5 · Secondary offeringJul 30, 2026
- 424B5 · Secondary offeringJul 29, 2026
Get alerts when INO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days